Physician

Urology

Raoul Salup practices Urology. He received awards:"Fellow (FACS)". Raoul Salup has written publications. He has 33 publications published with PubMed. The lastest publication is: 'Leiomyosarcoma with osteoclast-like giant cells of the spermatic cord. A case report and review of the literature.'

Publications

---

• Efficacy of vaccination with plasmid DNA encoding for HER2/neu or HER2/neu-eGFP fusion protein against prostate Cancer in rats.
• Cytokine-mediated protection of human dendritic cells from prostate Cancer-induced apoptosis is regulated by the Bcl-2 family of proteins.
• Diagnostic value of voided urine and Bladder barbotage cytology in detecting transitional cell carcinoma of the urinary tract.
• Leiomyosarcoma with osteoclast-like giant cells of the spermatic cord. A case report and review of the literature.
• Closure of large postradiation vesicovaginal fistula with rectus abdominis myofascial flap.
• Immunomodulation of natural killer activity by polyribonucleotides.
• Role of natural killer activity in development of spontaneous metastases in murine renal Cancer.
• Therapy of peritoneal murine Cancer with biological response modifiers.
• Therapeutic requirements for the successful treatment of mUrine renal carcinoma by adoptive chemoimmunotherapy.
• Successful treatment of advanced murine renal cell Cancer by bicompartmental adoptive chemoimmunotherapy.
• Treatment of adenocarcinoma in the peritoneum of mice: chemoimmunotherapy with IL-2-stimulated cytotoxic lymphocytes as a model for treatment of minimal residual Disease.
• Adjuvant immunotherapy of established murine renal Cancer by interleukin 2-stimulated cytotoxic lymphocytes.
• Augmentation of NK activity and/or macrophage-mediated cytotoxicity in the liver by biological response modifiers including human recombinant interleukin 2.
• Adoptive immunotherapy in combination with chemotherapy for Cancer treatment.
• Flavone-8-acetic acid augments systemic natural killer cell activity and synergizes with IL-2 for treatment of murine renal Cancer.
• Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
• Precursor phenotype of lymphokine-activated killer cells in the mouse.
• Adoptive immunotherapy of mUrine mammary carcinoma using broadly cytotoxic cloned T lymphocytes.
• Improved lymphocyte cytotoxicity against mUrine renal cell carcinoma.
• Chemoimmunotherapy of metastatic mUrine renal cell carcinoma using flavone acetic acid and interleukin 2.
• Challenges and potential solutions to meeting accrual goals in a Phase II chemoprevention trial for prostate Cancer.
• Relationship between hot flashes and distress in men receiving androgen deprivation therapy for prostate Cancer.
• Visualization of the neurovascular bundles and major pelvic ganglion with fluorescent tracers after penile injection in the rat.
• Safety of purified isoflavones in men with clinically localized prostate Cancer.
• A Phase II randomized, placebo-controlled clinical trial of purified isoflavones in modulating steroid hormones in men diagnosed with localized prostate Cancer.
• Total or partial prostate sparing cystectomy for invasive Bladder cancer: long-term implications on erectile function.
• The specific role of isoflavones in reducing prostate Cancer risk.
• Full-length dominant-negative survivin for Cancer immunotherapy.
• Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in Cancer.
• Caveolin expression in adult Renal tumors.
• Immunohistochemical expression of Mdm2 and p53 in penile verrucous carcinoma.
• Differential C-erbB-2 and VEGF expression following BCG immunotherapy in superficial papillary transitional cell carcinoma of the Bladder.

Schools

---

• PhilippsUniversitaet Marburg Fachbereich Medizin

• City Hospital

• Johns Hopkins University

• University Pittsburgh Hosps

• National Cancer Institute

Procedures Preformed

---

• Cystourethroscopy and Transurethral Resection of Bladder Neck
• Orchiectomy
• Urethral Dilation

Conditions Treated

---

• Bladder Cancer
• Bladder Stones
• Blood in Urine (Hematuria)
• Chronic Kidney Diseases
• View All

Doctors Specialties

---

• Urology

Accepted Insurances

---

• Aetna
• Blue Cross Blue Shield
• Cigna
• Commercial Insurance Company
• Emblem Health
• GEHA
• Choice Care PPO
• Preferred PPO
• Select HMO
• Tampa Bay CoreNet
• Tampa Bay HUMx HMOx
• Mail Handlers Benefit Plan (MHBP)
• Medicare MCR
• Mutual of Omaha
• Tricare
• United Healthcare

Awards

---

• Fellow (FACS)

Education

---

• University of Pittsburgh Medical Center
• Johns Hopkins University
• Philipps University of Marburg Faculty of Medicine

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Chandler D. Dora, MD This Doctor is OpenDoctor Recommended.
	Dr. Wade J. Sexton, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Raviender Bukkapatnam, MD This Doctor is OpenDoctor Recommended.
	Dr. Novelle D. Kirwan, MD This Doctor is OpenDoctor Recommended.
	Dr. Ronald W. Sadlowski, MD This Doctor is OpenDoctor Recommended.
	Dr. Timothy A. Weber, MD
	Dr. Yves L. Homsy, MD
	Dr. Mohendra G. Biswas, MD This Doctor is OpenDoctor Recommended.
	Dr. Mary K. Hall, MD
	Dr. Tod J. Fusia, MD This Doctor is OpenDoctor Recommended.
	Dr. Osvaldo F. Padron, MD This Doctor is OpenDoctor Recommended.
	Dr. Ricardo D. Gonzalez, MD
	Dr. Robert D. Bennett, MD This Doctor is OpenDoctor Recommended.
	Dr. Arash Rafiei, MD This Doctor is OpenDoctor Recommended.
	Dr. Bhavik B. Shah, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog